---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-017271"
form_type: "8-K"
ticker: null
cik: "0001522860"
company_name: "Acutus Medical, Inc."
filed_at: "2024-12-04T23:59:59+00:00"
generated_at: "2026-05-29T08:36:40.208159+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Acutus Medical cuts 70% workforce (~61 employees) and transitions CEO to consulting role

## Summary
- Workforce reduction of ~61 employees (~70%) expected to be completed by Q1 2025.
- Pre-tax exit charges estimated $1.4M-$1.8M; majority cash outlay in Q1 2025.
- CEO Takeo Mukai shifts to consulting role Feb 2025, retains titles, receives $10k/month.
- Company scales down to only support Medtronic left-heart access obligations; earnout potential until 2027.
- Cash on hand $12.6M as of Sep 30, 2024, expected to fund remaining business.

## SEC filing metadata
- accession: 0000950103-24-017271
- form_type: 8-K
- cik: 0001522860
- company_name: Acutus Medical, Inc.
- filed_at: 2024-12-04T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.05, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522860/000095010324017271/0000950103-24-017271-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522860/000095010324017271/dp221457_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-017271
- JSON: https://secwatch.observer/filing/0000950103-24-017271.json
- Plain text: https://secwatch.observer/filing/0000950103-24-017271.txt

## Key facts
- Restructurings & Charges
  Acutus Medical, Inc. announced a restructuring with charges of approximately $1.4 million to $1.8 million of pre-tax downsizing and exit-related charges affecting left-heart access manufacturing and distribution business (approximately 61 employees, representing approximately 70% of the Company's employees).
  - Type: restructuring
  - Charge: approximately $1.4 million to $1.8 million of pre-tax downsizing and exit-related charges
  - Affected area: left-heart access manufacturing and distribution business
  - Headcount: approximately 61 employees, representing approximately 70% of the Company's employees
  source text: The Company estimates it will incur approximately $1.4 million to $1.8 million of pre-tax downsizing and exit-related charges, of which approximately $0.3 million represents future cash expenditures for the payment of monetary consideration and related benefit costs, approximately $1.2 million represents future cash expenditures for the payment of retention bonuses to certain employees that will assist with the Downsizing, and potentially up to $0.3 million estimated as future cash expenditures for contract closing costs.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000095010324017271/0000950103-24-017271-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.